| P/E (FY) | — | Sales (TTM) | $2.72B |
| Earnings (TTM) | -$1.08B | ROE | — |
| Net Margin | −39.85% | ROIC | 39.92% |
| Debt / Equity | — | TD / EBITDA | 1.03 |
| EPS Growth 3Y | — | Sales Growth 3Y | −34.78% |
Accendra Health and its subsidiaries operate as a healthcare solutions company in the United States, providing in-home care and delivery products for diabetes treatment, home respiratory therapy including oxygen and ventilation, and obstructive sleep apnea treatment such as CPAP and bi-level devices. It also supplies home medical equipment and products spanning ostomy, wound care, urology, and incontinence, serving patients and home health agencies. Formerly Owens & Minor.
No price history for ACH — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
Diabetes Product 28% · Sleep Therapy Product 27% · Home Respiratory Therapy Product 16% · Product And Service Other 10% · …
No return history for ACH, so risk analytics are unavailable.
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| HSIC | HENRY SCHEIN INC | $9.76B | 26.2 |
| HDSN | HUDSON TECHNOLOGIES INC /NY | $266.7M | 17.1 |
| DBI | Designer Brands Inc. | $268.3M | — |
| PTLO | Portillo's Inc. | $268.8M | 16.1 |
| APC | ARKO Petroleum Corp. | $261.8M | — |
| MPAA | MOTORCAR PARTS OF AMERICA INC | $261.0M | 22.2 |
| ESCA | ESCALADE INC | $257.2M | 18.8 |
| JACK | JACK IN THE BOX INC | $277.5M | — |
| JILL | J.Jill, Inc. | $252.1M | 9.3 |
| JAKK | JAKKS PACIFIC INC | $280.4M | 28.5 |
| CURV | Torrid Holdings Inc. | $246.8M | — |
| NUS | NU SKIN ENTERPRISES, INC. |
| $246.6M |
| 1.6 |
